BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sahebjam F, Hajdu CH, Nortey E, Sigal SH. Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome. World J Hepatol 2016; 8(14): 632-636 [PMID: 27190580 DOI: 10.4254/wjh.v8.i14.632]
URL: https://www.wjgnet.com/1948-5182/full/v8/i14/632.htm
Number Citing Articles
1
Juan Putra, Thomas D Schiano, M Isabel Fiel. Resolution of HCV-Autoimmune Hepatitis Overlap Syndrome With Antiviral TreatmentAmerican Journal of Clinical Pathology 2019; 152(6): 735 doi: 10.1093/ajcp/aqz095
2
Kotaro Matsumoto, Kentaro Kikuchi, Yuta Namura, Ayako Watanabe, Hiromichi Tsunashima, Shinpei Doi. Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvirClinical Journal of Gastroenterology 2023; 16(4): 572 doi: 10.1007/s12328-023-01809-7
3
Camila C. Simoes, Omar A. Saldarriaga, Netanya S. Utay, Ashley E. Stueck, Sheharyar K. Merwat, Shehzad N. Merwat, Thomas D. Schiano, Maria Isabel Fiel, Heather L. Stevenson. Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune HepatitisHepatology Communications 2019; 3(8): 1113 doi: 10.1002/hep4.1388